Cadre (CDRE) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
23 Mar, 2026Company overview and business model
Manufactures highly engineered safety equipment for professionals, with 85% of 2025 revenue from product sales and 15% from owned distribution platforms.
Products serve over 23,000 first responders and federal agencies in 104+ countries, with 21 manufacturing facilities and 2,600+ employees.
Core product categories include duty gear, EOD, body armor, and nuclear safety.
Focus on innovation, with a legacy of patented products and continuous product launches.
Operating model emphasizes lean processes, leadership development, and continuous improvement.
Financial performance and outlook
FY2025 net sales reached $610.3M, up from $567.6M in FY2024; gross margin improved to 43.9%.
Adjusted EBITDA for FY2025 was $111.7M, with a margin of 18.3%.
FY2026 guidance projects net sales of $736M–$758M and adjusted EBITDA of $136M–$141M.
Net leverage at 12/31/25 was 1.7x, with $122.9M in cash and $307.3M in total debt.
198% total shareholder return since IPO, with 17 consecutive quarterly dividends declared.
Growth strategy and M&A activity
Completed six acquisitions since IPO, focusing on strong margins, recurring revenues, and market leadership.
Recent acquisitions include TYR Tactical (2026), Carr's Engineering (2025), Alpha Safety (2024), and ICOR Technology (2024).
M&A strategy targets new markets, enhanced category leadership, and increased customer wallet share.
Acquisition multiples ranged from 5x–11x, with disciplined criteria for asset-light, recurring revenue businesses.
Integration of acquired companies aims to leverage synergies and expand product offerings.
Latest events from Cadre
- Strong Q2 2026 results and raised FY2026 outlook reflect robust growth and successful M&A.CDRE
Investor presentation - Q2 2026 net sales rose 32%, with record backlog and raised guidance on strong demand.CDRE
Q2 2026 - Record backlog and robust growth in safety and nuclear markets drive strong 2026 outlook.CDRE
Investor presentation - Supplement amends 2025 executive compensation details; all other proxy matters remain unchanged.CDRE
Proxy filing - Q1 2026 net sales up 19%, record backlog, and major acquisitions support strong outlook.CDRE
Q1 2026 - Proxy covers director elections, auditor ratification, executive pay, and governance practices.CDRE
Proxy filing - Record EBITDA and net income growth in 2025, with double-digit 2026 outlook and higher dividend.CDRE
Q4 2025 - Nuclear safety and engineered products drive growth, margin expansion, and resilience.CDRE
Investor Day 2025 - Apex armor and robotics launches showcase innovation and global expansion focus.CDRE
Investor Update